@beau.livori's testosterone video raises key questions

What does this video actually claim?

This video doesn't make explicit medical claims about testosterone replacement therapy. Instead, @beau.livori posts a casual selfie with a caption referencing Italian and Maltese genetics, using hashtags that identify them as transgender and transmasculine.

The post appears in our TRT category, suggesting it's related to testosterone therapy for gender-affirming care. However, without clear therapeutic claims in the content itself, we're evaluating the broader context of TRT information that might be implied by the platform categorization.

What does the science say about testosterone therapy?

For transgender men and non-binary individuals, testosterone therapy shows clear benefits when properly supervised. The Endocrine Society Clinical Practice Guidelines (Hembree et al., Journal of Clinical Endocrinology & Metabolism, 2017) recommend testosterone cypionate or enanthate at 50-100mg weekly or testosterone gel at 50-100mg daily.

Research shows significant changes typically begin within 1-6 months. Voice deepening becomes noticeable at 3-12 months, with most changes complete by 1-2 years according to longitudinal studies tracking over 1,000 patients (T'Sjoen et al., European Journal of Endocrinology, 2019).

Side effects require monitoring. Polycythemia affects 5-20% of patients, while sleep apnea risk increases in those predisposed.

What's missing from this type of content?

Posts like this one don't provide medical context that followers might need. There's no mention of required lab monitoring, potential cardiovascular risks, or the importance of working with qualified healthcare providers.

The casual nature obscures the fact that testosterone is a controlled substance requiring prescription and regular medical oversight. Studies show unsupervised use leads to higher complication rates, including dangerous hematocrit levels above 54%.

Without explicit medical education, social media posts in medical categories can inadvertently minimize the complexity of hormone therapy.

What should people actually know about TRT?

Testosterone therapy requires comprehensive medical evaluation before starting. This includes checking baseline hormone levels, lipid panels, and hematocrit values.

For gender-affirming care, the World Professional Association for Transgender Health Standards of Care (Coleman et al., International Journal of Transgender Health, 2022) recommend psychological assessment and informed consent processes. These aren't barriers but safeguards to ensure optimal outcomes.

Regular monitoring every 3 months during the first year, then every 6-12 months, helps catch complications early. Blood pressure, lipids, and red blood cell counts all need tracking because testosterone affects these systems measurably.